Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

dual-target CAR-T cells BGT007

A preparation of human T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for two as of yet undisclosed tumor-associated antigens (TAAs), with potential immunostimulating and antineoplastic activities. Upon administration, the dual-target CAR-T cells BGT007 specifically recognize and induce selective toxicity in tumor cells expressing the two TAAs.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:bispecific CAR T cells BGT007
dual-target CAR T cells BGT007
Code name:BGT 007
BGT-007
BGT007
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search